H ealth information exchanges (HIEs) are healthcare information technology efforts designed to foster coordination of patient care across the fragmented U.S. healthcare system. Their purpose is to improve efficiency and quality of care through enhanced sharing of patient data. Across the United States, numerous states have enacted laws that provide various forms of incentives for HIEs and address growing privacy concerns associated with the sharing of patient data. We investigate the impact on the emergence of HIEs of state laws that incentivize HIE efforts and state laws that include different types of privacy requirements for sharing healthcare data, focusing on the impact of laws that include requirements for patient consent. Although we observe that privacy regulation alone can result in a decrease in planning and operational HIEs, we also find that, when coupled with incentives, privacy regulation with requirements for patient consent can actually positively impact the development of HIE efforts. Among all states with laws creating HIE incentives, only states that combined incentives with consent requirements saw a net increase in operational HIEs; HIEs in those states also reported decreased levels of privacy concern relative to HIEs in states with other legislative approaches. Our results contribute to the burgeoning literature on health information technology and the debate on the impact of privacy regulation on technology innovation. In particular, they show that the impact of privacy regulation on the success of information technology efforts is heterogeneous: both positive and negative effects can arise from regulation, depending on the specific attributes of privacy laws.
Introduction
The U.S. healthcare system is in the midst of an information technology revolution. Adoption of electronic medical record (EMR) systems is quickly rising (Office of the National Coordinator for Health Information Technology 2012). In parallel, health information exchanges (HIEs) have emerged. HIEs provide information technology solutions that allow electronic information sharing between otherwise disconnected healthcare organizations. They are intended to facilitate the exchange of patient health information between hospitals belonging to different health systems or distinct physician practices. In turn, this enables patients' health records to electronically follow them between care settings. HIEs are viewed as a particularly critical investment because much of the anticipated efficiency and quality gains from EMRs come from the ability to support the electronic exchange of patient data across healthcare providers (Walker et al. 2005) . Without HIEs, data are trapped in individual institutions, thereby inhibiting coordination of care, resulting in avoidable medical errors, and driving up costs from duplicative utilization. This has resulted in substantial legislative activity 1 aimed at realizing the vision of nationwide adoption of EMRs coupled with the ability to exchange data between them (Blumenthal 2010) .
Legislative efforts have focused on creating a favorable environment in which HIEs can flourish. The rationale for government involvement is that HIEs have experienced both slow growth rates and high failure rates across the United States (Adler-Milstein et al. 2009 . Research on the underlying causes of these failures revealed an array of barriers to the 1043 development of HIE efforts. Central among them are challenges related to financial sustainability (National eHealth Collaborative 2011, Vest and Gamm 2010 , eHealth Initiative 2005 and issues related to patient privacy (Simon et al. 2009 , McDonald 2009 , McGraw et al. 2009 ). These challenges have spurred 25 states (as well as the District of Columbia) to enact legislation to incentivize HIE efforts (e.g., by providing funding for HIE efforts), address privacy concerns, or, most often, both. However, the best approach to ameliorating the issues associated with HIE efforts remains unclear. In particular, HIEs have spurred significant debate over the appropriate balance of patient privacy and the potential gains to healthcare providers and their patients. The sensitivity of the digital health information that is exchanged by HIEs has made the role of patient consent especially contentious.
One side of the debate is that consent requirements add administrative costs and restrict the availability of patient information (National eHealth Collaborative 2011, Pritts et al. 2009 ). By contrast, Simon et al. (2009) find that patients felt that their consent should be obtained for the exchange of health information (i.e., an opt-in system); a system that assumed their willingness to participate without obtaining explicit consent (i.e., an opt-out system) would not be acceptable. Thus, policy makers seeking to foster the growth of HIE efforts face the same challenge that emerges in other industries: how to address privacy concerns without overregulating the disclosure of personal information and stifling the growth and emergence of valuable information technology efforts reliant on it.
Careful empirical literature related to that challenge has been recently emerging. Work by Miller and Tucker (2009) finds that the presence of privacy regulation inhibits technology adoption by hospitals. In subsequent work, Miller and Tucker (2011) account for some of the variation in the statutory requirements of privacy regulation and hospital characteristics, and they identify some heterogeneous effects of privacy regulation.
2 Adopting a similarly granular approach to measuring privacy regulation, we explore whether different forms of privacy regulation enable or impede HIE efforts. Extending prior work, we differentiate between states that coupled privacy regulation with HIE incentives and those that did not. We posit that incentives could offset the significant costs associated with HIE efforts, including those that arise from varying degrees of privacy regulation. We evaluate the impact of these laws compared to states with no laws pertaining to HIE efforts.
Our empirical strategy takes advantage of the fact that across different states policy makers have approached HIE challenges in different ways, enacting legislation that varied both in terms of the incentives they create for HIEs, and in terms of the types of privacy protections they afford to patient data exchanged through HIEs. Specifically, some states enacted legislation with HIE incentives alongside requirements for patient consent while other states enacted legislation with HIE incentives but with privacy regulation that did not require consent. Yet other states enacted legislation with HIE incentives but no privacy regulation or only privacy regulation, or they did not enact relevant legislation at all. Our work leverages this variation to evaluate the impact of this legislation-in particular, the variation in privacy protection afforded by these laws-on the propensity of regional healthcare markets to have an HIE working toward exchange capabilities (planning HIE) or an HIE that is actively exchanging patient health information between healthcare entities (operational HIE). We use semiannual data from a six-year period (2004) (2005) (2006) (2007) (2008) (2009) to compare the probability of a hospital referral region (HRR) 3 having an HIE in the planning or operational stage across states with variation in the extent to which legislation provided patients the right to consent to the exchange of their data by the HIE. We disentangle the impact of consent requirements from HIE incentives using between-state and acrosstime variation in consent requirements and regulations providing HIE incentives. We include HRR and time fixed effects and control for relevant observables (e.g., other elements of the laws, differences in HRR wealth, populations, health information technology (IT) adoption).
Although we show that privacy regulation without incentives had a negative effect on HIE efforts, we also find that privacy regulation, particularly regulation that includes consent requirements, was a necessary condition for incentives to positively impact HIE efforts. Incentives coupled with privacy regulation that included requirements for patient consent resulted in a 47% increase in the propensity of an HRR having a planning HIE and a 23% increase in the propensity of an HRR having an operational HIE. By contrast, incentives without any privacy regulation resulted in no measurable gain in the propensity of HRRs having planning or operational HIEs, and 3 HRRs are areas defined by the Dartmouth Atlas for Healthcare as regional healthcare markets for tertiary medical care that contain at least one hospital that performs major cardiovascular procedures and neurosurgery (Wennberg and Cooper 1996, p. 201 Management Science 62(4), pp. 1042 pp. -1063 pp. , © 2016 incentives coupled with privacy regulation that did not include consent requirements resulted in either no gains (e.g., for planning HIEs) or comparably modest gains (a 9% increase in the propensity of an HRR having an operational HIE) that only offset but did not overcome the baseline negative effects of privacy regulation. As a result, of all attempts to incentivize HIE efforts, only those coupled with privacy regulation including consent requirements resulted in a net gain in HIE efforts. Specifically, HRRs in these states saw an 11% net increase in the propensity of having an operational HIE.
Our findings are bolstered by the fact that we do not find evidence that HIE laws are passed as a result of increased HIE activity (i.e., reverse causation). We find consistent results when we consider the impact of unobservable state characteristics that may be correlated with the passage of HIE incentives (such as changes in political attitudes or public opinion toward the importance of health IT). Moreover, we find no correlation between consent requirements and the availability of funding or the number of patients covered by an HIE. We theorize that this surprising interplay between HIE incentives and consent requirements may be due to an association between incentives and privacy concerns. Specifically, we posit that incentives may be associated with an increased attention to and salience of HIE privacy concerns, which inhibits their effectiveness when they are not coupled with comprehensive privacy regulation (e.g., regulation with consent requirements). We find evidence in support of this interpretation: HIEs in states with incentives but no consent requirements were significantly more likely to report that privacy was a major challenge in their development relative to HIEs in states with other legislative approaches (including no law). By contrast, HIEs in states with consent requirements reported the lowest level of privacy concerns.
Our work contributes to two streams of literature. One stream relates to the adoption and the diffusion of IT in healthcare-in particular, the factors and barriers that impact their adoption (Angst and Agarwal 2009 , Angst et al. 2010 , Anderson and Agarwal 2011 . Specific to HIEs, numerous national surveys have suggested that health privacy issues are some of the most significant barriers to HIE efforts (eHealth Initiative 2005 , Adler-Milstein et al. 2009 . As a result, research has also focused on how to address privacy concerns associated with information technology in healthcare and HIE in particular (Greenberg et al. 2009 , McDonald 2009 , McGraw et al. 2009 ). Within this stream of literature, which is largely nonempirical, experts disagree on the appropriate solution for addressing privacy concerns. To our knowledge, our work is the first to empirically evaluate the impact on the emergence of planning and operational HIEs of varying approaches to privacy regulation.
Another stream relates to the economic and policy literature evaluating the impact of privacy protections on technological progress. Numerous consumer services thrive today thanks to the exchange and use of personal-and sometimes sensitive-information. The risks associated with the potential misuse of that information, however, have fueled a debate over the best approach to protecting consumers' privacy and the role of regulation in that protection (Solove 2004, Lenard and Rubin 2005) . This has led to a small but growing body of careful empirical analyses of that relationship (e.g., Tucker 2009, 2011; Goldfarb and Tucker 2011) . We extend that work in various ways. First, this literature has either focused on contexts where technology incentives did not exist or (as in the case of work in the context of health IT) predated a paradigm shift in the policy approach toward promoting health IT. Focusing on the interaction of various forms of privacy regulation with previously unstudied attempts to promote information technology efforts in healthcare, we document a surprising interplay between state initiatives aimed at incentivizing HIE efforts and privacy regulation. We find that HIE incentives consistently offset the negative baseline effects of privacy regulation on HIEs and, more surprisingly, that incentives were more effective in doing so when coupled with privacy regulation that included consent requirements. This suggests that the potential fixed costs that arise from regulatory privacy protection may be proactively managed by accompanying incentives for information technology efforts. Interestingly, coupling more comprehensive privacy protections (e.g., consent requirements, which seemingly impose higher costs on HIEs) with HIE incentives may sometimes be preferred if those protections alleviate privacy concerns that dampen the propensity of incentives to enable HIE efforts. Furthermore, research is emerging that points to heterogeneous effects of privacy regulation on information technology efforts (e.g., the net effect of privacy regulation on hospital IT adoption may depend on the number of hospitals in a county; see Miller and Tucker 2011) . By documenting the differential impacts on HIE efforts of privacy regulation with and without incentives, we extend the understanding of the heterogeneous effects of privacy regulation on technology efforts. Thus, the findings presented here suggest that regulators may have an opportunity to provide meaningful privacy protection to patients while encouraging the growth and success of valuable information technology efforts. For instance, legislative efforts such as the HITECH Act of 2009, which couple significant incentives for health Downloaded from informs.org by [128.237.116 .93] on 16 March 2018, at 08:44 . For personal use only, all rights reserved.
IT with enhanced privacy protections for patients, may offer an effective approach toward providing improved patient privacy protections while encouraging the growth of valuable health information technology solutions.
Background
The healthcare delivery system in the United States is highly fragmented. Most people, over their lifetime, receive care from multiple medical providers who practice in unaffiliated settings. As a result, different pieces of a patient's medical history reside in the various places in which they received care, forcing medical providers to make clinical decisions with incomplete information. This can contribute to a range of negative patient consequences, including missed diagnoses, duplicative testing, dangerous combinations of medications, and poor care coordination. Prompted by estimates of gains in quality 4 and efficiency 5 of patient care, enabling clinical data to electronically follow patients between care delivery settings has gained substantial support. In particular, in recent years, there has been an increase in efforts to facilitate electronic exchange of patient data via HIEs.
HIEs are information technology service organizations that provide a governance framework and technology solution for exchanging patient data. Entities with clinical data, such as hospitals, physician practices, and laboratories ("healthcare entities"), are the most common participants in an HIE, and they most often send and receive test results as well as care summaries.
HIE development typically occurs in two stages: planning and operational. In the planning stage, a group of healthcare stakeholders in a given community initially come together informally to discuss the problem of care fragmentation and how best to address it. This is typically initiated by a large stakeholder in the community, either a healthcare delivery organization (e.g., a large hospital) or a payer (e.g., an insurer or large employer). If there is agreement to 4 Gains in quality of care may be realized from the increased availability of comprehensive health information, which should allow clinicians to make better treatment decisions and fewer mistakes. This benefit would be especially salient in the emergency care context, in which the patient may not be able to report preexisting conditions or drug allergies (Vest and Gamm 2010) . 5 Health information exchanges have the potential to significantly decrease the costs of providing healthcare. Walker et al. (2005) estimate that, when fully implemented, health information exchanges could yield approximately $78 billion in annual savings from administrative efficiencies and reducing redundant utilization. Jha et al. (2009) estimate that, in the United States, eliminating avoidable instances of injury to a patient resulting from a medical intervention, such as administering the wrong medication, and redundant medical tests would save over $24 billion per year. move forward into a more formal planning phase, this often proceeds in one of two ways: either a third-party organization is established or identified to serve as a formal HIE entity or one of the stakeholders agrees to serve as the lead entity. In our data set, two-thirds of efforts operated as established, independent organizations and the remaining one-third operated directly from within another organization (typically a hospital or health system that spearheaded the effort). The formal planning phase consists of an array of interrelated decisions that include conducting an environmental scan and needs assessment, establishing a mission and goals, setting up a governance structure, establishing legal and information sharing agreements, deciding on an approach to protect patient privacy (including patient consent), developing a sustainability plan and identifying revenue streams that at least cover operating costs, marketing to a broader group of potential stakeholders, and developing a technical infrastructure.
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The second stage begins when an HIE effort reaches operational status with a functional technology and administrative infrastructure and data start to be exchanged between healthcare entities. Although this is considered a key milestone, HIEs in this stage continue efforts to increase participation from healthcare entities: increasing the quantity and quality of patient data available through an HIE makes the expected benefits of exchange more likely and also helps HIEs to achieve financial sustainability (only 33% of operational exchanges in our data set reported covering the cost of operating an HIE with participant fees alone).
The last decade has seen significant growth in HIE activity, including the number of planned HIEs and an increasing number of HIEs that are operational: in our data, we observe 15 total HIEs nationwide in 2004, compared to 143 by the end of 2009. Despite substantial potential benefits, HIEs are not yet widespread, and many attempts to establish HIEs have failed (Adler-Milstein et al. 2009 . This has spurred a growing body of work evaluating barriers to HIEs, which suggests that they have been hindered by financial sustainability challenges stemming from misaligned incentives from competing healthcare entities and patient privacy concerns (eHealth Initiative 2005 , Adler-Milstein et al. 2009 .
HIE Incentives
Numerous HIEs have struggled to develop a sustainability plan and identify revenue streams. In part, this is due to misaligned incentives for HIE participants (who are the primary source of HIE revenue) and the significant cost attached to the administrative and technical infrastructure necessary to facilitate exchange. Although healthcare entities can derive Management Science 62(4), pp. 1042-1063, © 2016 INFORMS some value from participating in an HIE (e.g., better quality of patient care), under the predominant healthcare reimbursement model of fee-for-service, redundant care translates into revenue, and physicians have little incentive to avoid care if they believe it is of even marginal value. Worse, HIE makes it easier for patients to switch healthcare providers, potentially resulting in some hospitals and physicians losing patients. Moreover, healthcare entities (e.g., hospitals and physician practices) are expected to pay for HIE when those paying for care accrue much of the benefit. For example, if a physician avoids ordering a redundant test because he or she has access to the results of a diagnostic test performed in a different setting, the physician (or laboratory) loses revenue while the payer (and, downstream, the patient) accrue the savings. The challenges in sustaining HIE efforts that stem from these misaligned incentives for healthcare entities have been exacerbated by the high costs of HIE efforts, with considerable resources required to develop administrative and technical infrastructure that meets regulatory requirements (e.g., privacy regulation) while also addressing the concerns and needs of various HIE stakeholders. These challenges have led some to argue that HIE should be treated as a public good with support from the government (e.g., Vest and Gamm 2010) .
A number of states have heeded these calls, enacting legislation that attempts to alleviate these concerns by incentivizing HIE efforts. Specifically, various state legislations included general provisions aimed at reducing the costs (financial, legal, managerial, coordination, or otherwise) associated with pursuing a health information exchange effort in the state. These laws and their typical provisions are described in more detail in §4.2.
HIEs and Privacy
Issues of privacy are among the most widely cited barriers to HIE formation (Simon et al. 2009 ) and have materialized as significant costs to HIEs. HIEs differ from other forms of health IT (e.g., EMRs) in ways that have important implications for patient privacy. First, HIEs facilitate the exchange of information between multiple, unaffiliated organizations; thus the risk to the privacy of health information and associated concerns expressed by consumers may be substantially greater than with other technologies. Also, HIEs are predicated on the idea of exchanging individual personal health information as opposed to aggregated population-level data, making privacy concerns salient and relevant. These unique challenges have spurred a stream of literature evaluating how to best address privacy concerns while still encouraging HIE efforts (Greenberg et al. 2009 Although the stakeholders initiating HIE efforts and the specific model they pursue can vary, the mechanism underlying the choice of stakeholders to start planning for exchange and whether or not an HIE becomes operational is the same: HIEs can only create value if healthcare entities (i.e., those with clinical data) participate in an HIE, which typically involves adhering to the terms set forth by the HIE and using its offered technology solutions to receive and send patient health information. The choice of healthcare entities to participate in an HIE is driven by an assessment of the costs and benefits that they will accrue. For example, a hospital would incur technical costs, participation fees, and potential loss of patients as a result of reduced switching costs, as well as the increased legal risk from a data breach or misuse of patient data. This would be weighed against potential quality and efficiency gains from electronic access to more complete information about their patients, as well as reputational benefits from joining a community-based effort to improve care coordination. In addition, a broader group of stakeholders, which do not deliver care, may stand to benefit from cost reductions as a result of HIE and could also influence efforts to plan for an HIE and whether it becomes operational. For instance, a large payer may participate in an HIE effort and subsidize the costs to healthcare entities in order to encourage broader participation. This could be particularly likely if the net benefit to healthcare entities (absent these subsidies) was not sufficiently compelling to promote widespread participation (e.g., because of the misaligned incentives described earlier). In the remainder of this section, we discuss how varying forms of Downloaded from informs.org by [128.237.116 Stigler (1980) and Posner (1981) , regulating the use of patient data may decrease availability of their information when it is needed by healthcare providers to make decisions, making promised benefits less likely. Regulation may also increase the cost of establishing and maintaining an HIE (for instance, by imposing additional technological controls or administrative procedures to protect individuals' data). On the other hand, privacy regulation may have a positive effect on the choice to pursue an HIE. An established literature finds that privacy concerns can increase the cost of technology adoption and reduce its effectiveness Agarwal 2009, Sheng et al. 2008) . As a result, scholars have argued that assurances provided by regulation can assuage privacy concerns and positively impact the success of information technology efforts (Bamberger and Mulligan 2011, McGraw et al. 2009 ).
Naturally, privacy regulation is not monolithic; the extent to which privacy regulation impacts the benefits and costs of HIEs likely depends on the degree and type of reassurance it affords. In particular, one of the key differentiating features between regulatory approaches in the context of HIE is whether they include requirements for patient consent. Consent, or informed consent, is a cornerstone of the Organisation for Economic and Cooperative Development's privacy guidelines and the Federal Trade Commission's Fair Information Practice Principles. Generally speaking, consent in the context of HIE refers to the notion that patients should be informed about the risks and benefits associated with the electronic exchange of their health information and have the right to decide whether they would like to incur them. As in the case of privacy regulation in general, regulation specifically requiring consent can, in principle, produce an array of effects, both positive and negative, on the emergence of planning and operational HIEs. A central concern relative to patient consent in the context of HIE is that it may result in limited or patchy patient agreement to have their data included in the HIE (Lai and Hui 2006) , in which case the potential benefits of HIE may be hindered. Healthcare entities may be less willing to participate in an HIE if they perceive a low likelihood of reaping efficiency and quality gains as a result of incomplete or low-quality patient data. Moreover, other stakeholders (e.g., payers) may be less willing to support an HIE effort (i.e., subsidize the cost to healthcare entities) if they perceive the benefits to be unlikely. Furthermore, requirements for consent are also likely to impact HIEs' technology and administrative costs (i.e., in establishing more stringent legal agreements) and participation costs for healthcare entities (i.e., costs for participants to adhere to them). For example, HIEs operating in states with consent requirements may need additional investment in technical and administrative controls to meet regulatory requirements (e.g., clerical time by staff or technical controls to garner and track patient consent decisions). Hence, consent requirements may further reduce the propensity of a healthcare entity to participate in an HIE if they perceive participation to be too costly to justify their expected benefits.
On the other hand, regulations with consent requirements can reduce costs stemming from patient privacy concerns. Patients may demand the right to consent to the use of their data in the context of an HIE. Simon et al. (2009) find that patients felt that an HIE that assumed their willingness to participate without obtaining explicit consent (i.e., an opt-out system) would not be acceptable. As a consequence, healthcare entities may decide not to participate in HIEs if a lack of patient consent results in significant privacy costs and pushback from patients and advocacy groups. McGraw et al. (2009) argue in support of this notion and propose that a comprehensive framework that implements core privacy principles such as consent can bolster trust from patients and medical providers. In contrast to previously described effects of privacy regulation, a reduction in costs stemming from privacy concerns may encourage increased participation by healthcare entities, thus helping HIEs to reach the critical mass of participants to ensure that anticipated benefits are realized.
The role of privacy regulation that does not include consent requirements is also of interest because numerous states have privacy legislation that does not require patient consent before the exchange of health information between providers. For example, legislation in the state of Indiana does not include requirements for patient consent but instead, requires compliance "with the federal Health Insurance Portability and Accountability Act (HIPAA)" and the protection of "information privacy."
7 It is likely that the role of regulation that does not require consent is similar to consent-based regulation except that the impact on benefits and costs (and the propensity of community stakeholders to pursue HIE efforts) may be less pronounced. For example, privacy regulation that does not include consent requirements may still restrict (to some degree) the availability of patient information and also introduce additional costs to HIE efforts, but these effects may not be as pronounced when compared to regulation with consent requirements. It may also be the case that regulation without consent is not as effective in reducing costs to HIE efforts stemming from patient privacy concerns. In fact, we argue that this is likely the case. Recent experimental work suggests that providing consumers with choice relative to the use of their personal information may be particularly vital in assuaging privacy concerns. Brandimarte et al. (2012) find that individuals who were provided increased choice perceived a lower privacy risk, even when the objective risks were held constant, and were significantly more likely to make personal disclosures; Stutzman et al. (2013) find a strong positive correlation between the granularity of control provided to users of online social networks and the amount of disclosure by users (albeit to a narrower set of users). These mechanisms are also likely to be present in the context of HIEs, given the sensitivity of personal health information. Finally, policy makers have also recognized the unique role of providing choice by increasingly promoting more control for consumers with respect to online uses of their personal information (Federal Trade Commission 2012, White House 2012).
Incentives and Privacy Concerns
The impact of HIE incentives on the benefits and costs of establishing an HIE seem, at first glance, comparatively straightforward: all else equal, stakeholders with access to incentives that reduce the costs of pursuing an HIE effort should be more likely to start planning for exchange, and these HIEs should be more likely to become operational. For instance, stakeholders in communities with access to grant programs associated with HIE incentives would have less of a challenge generating the required capital to initiate exchange efforts and be able to provide healthcare entities the opportunity to participate at a lower cost (thus increasing the likelihood of more widespread participation and the propensity of reaping expected benefits from exchange). Additionally, given the potential of privacy requirements to impose fixed costs on information technology efforts (e.g., Goldfarb and Tucker 2011, Miller and Tucker 2009 ) and the anecdotal evidence that privacy requirements have been key hurdles for HIE efforts, incentives may serve to offset some of these costs and attenuate some of the negative effects of privacy regulation on the propensity of HIE efforts to emerge.
However, there may also be a more nuanced and less obvious interplay between incentives, privacy concerns, and the impact of privacy regulation and incentives. Specifically, legislation intended to encourage the pursuit of HIE efforts may also be associated with elevated salience and awareness of privacy concerns. We see examples of a similar phenomenon in other contexts: government subsidies for clean energy solutions have led to significant investment in these technologies but have simultaneously highlighted the limitations and potentially adverse effects of these technologies (e.g., lack of cost effectiveness and efficacy); see Somaskanda (2013) and Cala (2013) . With respect to HIE incentives, they may be seen to increase the probability that HIEs will be created and become operational and thereby increase the likelihood of patient privacy concerns being realized. Moreover, it may simply be the case that HIE incentives increase the attention paid to these efforts (e.g., by regulators, patient groups, and privacy advocates), including increased attention to associated privacy concerns. There is some anecdotal evidence in support of this notion. For example, the American Civil Liberties Union brought suit against the legislatively created Rhode Island HIE on the grounds that it was not adequately soliciting consent from patients, and privacy advocates warned that states "will find themselves embroiled in legal entanglements over privacy as they seek to implement HIEs" (Miliard 2010 ). This latter statement suggests that state-supported HIEs (such as those initiated or aided by state legislation) may receive disproportionate scrutiny from privacy advocates. It is also possible that the direction of causality is reversed: states in which the attention to health information exchange, including attention to privacy concerns, is high may be more likely to provide HIE incentives.
Conceptual Model and Predictions
Although we cannot directly observe the granular benefits and costs to various stakeholders from HIE participation, we can observe variation in the propensity of healthcare stakeholders to start planning for exchange capabilities (PlanningHIE) and whether these exchanges start actively exchanging patient health information between healthcare entities (OperationalHIE). We argue that these observed variables are, in turn, a function of the unobserved expected benefit and costs of an HIE effort to potential HIE stakeholders, NetRegionalBenefit. Moreover, we model the choice to pursue an exchange at the level of a state subregion j since HIEs have emerged predominately as regionally focused efforts.
8 Scholars suggest that this regional focus is due to the significant variation between healthcare markets (even within a given state) and the nuanced challenges this variation can introduce for the pursuit of HIE efforts (Grossman et al. 2008) . For example, the necessary collaborations, technology infrastructure, and the priorities of participating providers are likely to differ considerably between the healthcare market in metropolitan and rural regions of a state (e.g., Manhattan versus upstate New York). Moreover, an HIE's goal is to enable clinical data to electronically follow patients between the settings in which they receive care, which also are predominantly within a defined geographic region. Hence, we utilize HRRs as our unit of analysis because they represent regional healthcare markets. 9 In effect, HRRs are defined precisely to capture the geographic regions in which patients are likely to receive the bulk of their care and thus require the exchange of information. Finally, and consistent with the preceding arguments, we suggest that various forms of privacy requirements (PrivConsent/PrivNoConsent) and legislative provisions intended to encourage the pursuit of HIE efforts (Incentives) can affect the benefits and costs of HIE efforts to stakeholders within the various healthcare markets in a state, impacting the choice of stakeholders to start planning for exchange and whether these HIEs becomes operational. This is summarized in the following conceptual model (based on Miller and Tucker 2009):
This model assumes a latent variable construct where stakeholders in HRR j in state s at time t start planning for an HIE if the (unobserved) expected net benefit (NetRegionalBenefit) is positive. Moreover, we assume that an HIE effort in the region reaches operational status if the NetRegionalBenefit remains positive such that they are able to complete key planning activities (e.g., create data sharing agreements, develop the underlying technical infrastructure, and gather the critical mass of participation by healthcare entities to make exchange feasible). Conversely, healthcare stakeholders will not form exchanges if they perceive the net benefit to be negative, and healthcare entities will cease pursuing HIE efforts (resulting in failed exchange) if they perceive the net benefit from HIE to no longer be positive. The arguments from this conceptual model and the various dynamics described in this section are summarized in Figure 1 . This figure suggests that the net effect of privacy regulation on HIE efforts is a function of (1) the costs associated with privacy regulation; (2) the extent to which privacy concerns are, in fact, barriers to the pursuit of HIE efforts; and (3) the likelihood of available regulation to alleviate these concerns. With this in mind, we first consider the simplest case where privacy regulation is enacted without accompanying incentives (i.e., the left-hand side of Figure 1 ), where we consider it more likely that privacy regulation will have a negative overall effect on NetRegionalBenefit, thus reducing the likelihood that HIEs form and become operational (this is similar to what has been shown in the current empirical literature). This implies that the propensity of privacy regulation to reduce the NetRegionalBenefit from HIE as a result of increased implementation costs and the restrictions on the availability of patient data ( 1 2 are likely to outweigh any gains from reduced patient privacy concerns ( 1 2 . Moreover, taking into account the propensity of consent requirements to have more substantial negative effects on NetRegionalBenefit ( 1 > 2 ), this effect may be more pronounced for legislation including consent requirements.
The introduction of HIE incentives, however, introduces a more complex and interesting dynamic. Focusing only on the propensity of incentives to reduce HIE costs ( 3 , incentives alone may positively impact NetRegionalBenefit, and, if passed alongside privacy regulation, HIE incentives could offset some of the costs of privacy regulation. However, if we also consider the potential of incentives to be associated with elevated privacy concerns ( 3 that then offset the positive effects of HIE incentives on NetRegionalBenefit ( 4 , we may observe a more nuanced effect of both incentives and privacy regulation on HIE efforts. First, we may see a limited positive effect on NetRegionalBenefit of incentives passed alone because of the dampening effect of the simultaneously elevated privacy concerns ( 3 . Moreover, this suggests that privacy regulation, and in particular consent regulation that can better alleviate patient privacy concerns ( 1 > 2 , may become a more prominent force in this dynamic and could play a critical role in unlocking the propensity of HIE incentives to positively impact the net benefits of exchange. The implication of this is that coupling consent requirements with HIE incentives may have a stronger positive impact on NetRegionalBenefit (and thus differentially increase the propensity of regional stakeholders to start planning for exchange and these exchanges becoming operational) relative to incentives with privacy regulation that did not include consent requirements or with no accompanying privacy regulation. Further, this suggests that privacy regulation may have considerably different (and potentially opposite) effects on HIEs depending on whether incentives are also in place.
Data
Our analysis uses a combination of a six-year panel data set and cross-sectional HIE survey data to assess Downloaded from informs.org by [128.237.116 Effects of Legislation on HIE Formation the impact of the different legislative approaches on planning and operational HIEs. Consistent with the literature, we define an HIE as any entity that facilitates electronic health information exchange between independent healthcare entities in a defined geographic region to improve health (Adler-Milstein et al. 2009 ). As a result, the HIEs in our data set predominately focused on the exchange of patient health information between medical providers for patient treatment purposes. Further, we consider facilitation to be providing a technical infrastructure to support clinical data exchange. Together, these criteria exclude efforts whose entire scope is limited to administrative data exchange as well as efforts working on issues related to HIE but not directly enabling it to occur.
Panel HIE Data
To identify HIEs across regions and time, we used publicly available data from the eHealth Initiative's annual compilation of state, regional, and local HIE efforts (eHealth Initiative 2005 • Planning: The HIE has been initiated but is in the planning stages of development and is not actively sharing health information n = 132 .
• Operational: The HIE is actively enabling the exchange of health information between healthcare entities n = 88 .
We also identified 92 HIEs that had been initiated during this time period but had subsequently ceased operations. We do not have longitudinal data on these exchanges, and they are not included in our panel data. However, using cross-sectional data on the total number of failed HIEs in our time period of analysis, we find no significant differences in failed exchanges between legislative approaches.
10 To identify the date on which HIEs were initiated and became operational and their geographic area of operation, we matched HIEs in the eHealth Initiative survey data with a national survey of HIEs collected in 2010 that captured detailed information on HIEs as of the end of 2009 (Adler-Milstein et al. 2011) . Our sample includes the 73 planning and 75 operational exchanges common to both data sets minus 5 exchanges that were dropped because they did not report detailed information on their geographic location, resulting in 143 exchanges (70 planning and 73 operational) in our panel data set.
On average, HIEs in our data set had been in existence for approximately four years, and the subset of HIEs that were operational had been exchanging health information for three and a half years by the end of 2009. Most exchanges (86%) operated within a single state; nearly all exchanges (98%) were operating in fewer than two states. HIE geographic coverage was measured at the more granular level of an HRR. HRRs are generally contained within a single state but can span multiple states and, in some cases, can also span legislative approaches (although this was not common).
11 Of the operational exchanges, 70% reported covering a single HRR, and 60% of the planning exchanges anticipated covering a single HRR. The exchanges that were operational or planning in multiple HRRs tended to have the majority of their coverage in a single HRR, and thus we considered only their primary HRR. For example, of the 22 exchanges that reported operating in multiple HRRs, 20 reported being primarily operational in a single HRR with more than 70% of their overall coverage in a single HRR. 12 We aggregated HRR coverage across individual HIEs to generate two primary dependent variables.
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• PlanningHIE jst : A binary measure of whether HRR j in state s at time t had one or more HIEs in the planning phase. This measure only includes HIEs that had not failed and were available to take the HIE survey in 2010.
• OperationalHIE jst : A binary measure of whether HRR j in state s at time t had one or more operational HIEs.
These variables are created semiannually over the period [2004] [2005] [2006] [2007] [2008] [2009] to most accurately capture the impact of legislation on HIEs, which commonly went into effect at the beginning or the middle of the year.
To construct measures of HRR demographics, including measures of HRR population, income, and unemployment rates, we used a range of secondary sources (e.g., U.S. Census Bureau, U.S. Bureau of Economic Analysis, and the U.S. Department of Health 11 In our analysis we find that only 9% of HRRs had significant portions (more than 25%) of the populations they encompass in other states with different legislative approaches. Our results are robust to the exclusion of these HRRs. 12 On average, HIEs were operational in 9.5 hospital service areas (HSAs)-a collection of ZIP codes whose residents receive most of their hospitalizations from the hospitals in that area (Wennberg and Cooper 1996) In addition to our semiannual panel data set, we constructed a cross-sectional data set using HIE survey data. These data, which were only available for the final year of our data, offered a detailed snapshot of HIE activities, including a range of self-reported measures that captured qualitative differences between HIEs. We used this cross-sectional data to examine other dimensions of HIE progress that were not captured in our panel measures of HIE efforts. For example, these data include measures of the number of patients covered by an exchange, organizational structure, sources of funding, and challenges faced. We supplemented this with data from other sources to construct state-level measures of education levels, age structure, and political leaning. Table 1 includes the full list of measures and associated summary statistics.
Legislation
Protection of patients' personal health information, as well as requirements for patient consent for the sharing of personal health information in the context of exchanges, is governed by a combination of federal and state laws.
At the federal level, patient consent is governed primarily by HIPAA 14 and associated regulation. HIPAA was amended in 2009 by the HITECH Act, which added some privacy requirements, including breach notification requirements for entities covered by HIPAA. 15 Although HIPAA laws impact the disclosure of health information by HIEs, HIPAA applies to all states (our analysis relies on between-state variation) and was passed before the time period of our analysis. HITECH was passed in our period of analysis, and its effect on HIE efforts is accounted for by the time fixed effects in our models. At the state level, two types of privacy legislation may affect HIE outcomes: (1) general privacy health laws, not HIE specific, that were largely enacted before the significant emergence of HIEs; and (2) HIE-specific laws aimed at promoting HIE activities and/or focusing on the disclosure of patient data and patient consent.
General health privacy laws (i.e., not HIE specific) have historically been in place to deal with various aspects of health privacy, including disclosure of patient health information and consent. We to disclose all types of health information and only three (New York, Minnesota, and Vermont) usually require medical providers to obtain patient permission before disclosing health information to other providers. Because general health privacy laws that are not HIE specific were passed before our period of analysis, and their requirements for consent have limited applicability to HIEs, we do not use them as focal independent variables. The states with requirements relevant to the exchange of health information were included in our analysis as interactions with time-varying HIE-specific legislation. This accounts for states that may not provide explicit requirements for consent in HIE-specific legislation because their existing legislation already has relevant requirements.
Our primary independent variables capture HIEspecific laws that, unlike general health privacy laws, were passed in the period of our analysis and have direct applicability to exchange efforts. We identified HIE-specific laws primarily through various legal search services (e.g., LexisNexis Academic and Westlaw) and supplemented these searches with recent reports on disclosure laws and HIEs (Goldstein and Rein 2010) . We find that, in the past decade, various states enacted legislation that (1) incentivized HIE efforts, (2) addressed patient privacy and consent, or, most commonly, (3) some combination of both.
As we described earlier, we considered state legislation as providing HIE incentives if it included, at a minimum, general provisions aimed at reducing any of the costs (financial, legal, managerial, coordination, or otherwise) associated with pursuing a health information exchange effort in the state. Our review of state laws fitting this criterion yields a number of state laws with provisions to incentivize HIE efforts. For instance, the North Dakota state law directs its health information technology office to "facilitate and expand electronic health information exchange in the state, directly or by awarding grants"; 16 West Virginia law requires the director of the Office of Health Enhancement and Lifestyle Planning to work "through the West Virginia Health Information Network, the Bureau for Medical Services and other appropriate entities, to develop a collaborative approach for health information exchange"; 17 and Kentucky state law tasks the Kentucky eHealth network board with responsibility for "the operation of an electronic health network in this Commonwealth" and, among other things, for making recommendations related to "models for an electronic health network" and "financing the central interchange for the network." 18 North Dakota state law included provisions to create an "electronic health information exchange fund" and also instituted a "health information technology loan program." We found seven states that had HIE incentives focused on creating or designating a specific statewide HIE as opposed to focusing on dispersed regional efforts (such provisions do not exclude other entities from creating additional exchanges in that state). For instance, Rhode Island state law established a "statewide HIE under state authority to allow for the electronic mobilization of confidential health care information," 20 and Vermont state law tasked the Vermont Information Technology Leaders (a nonprofit organization within the state) with operating the "statewide health information exchange network for this state" that included "grant agreements" with the organization. 21 We account for this variation in the specific provisions included as part of state laws incentivizing HIE efforts in our empirical analysis.
Similar to general health privacy laws, HIE-specific laws varied in the extent to which they provided patients with privacy protections and, in particular, the extent to which they instituted requirements for consent. Given that most states' general health privacy laws 22 do not include consent requirements for disclosing health information 23 to other providers (which are also the majority of HIE participants), requirements for consent in HIE-specific laws are especially relevant to the disclosure of health information by exchanges. As a result, we differentiate between legislation including provisions requiring consent, only general privacy requirements without consent, and no privacy requirements at all. Leveraging variation in HIE incentives and privacy requirements between states, we categorize states that 22 New York, Minnesota, and Vermont have some requirements that require consent for disclosure between providers. These states were treated as having consent requirements and are Incentives and PrivConsent states because they would all subsequently pass HIEspecific legislation. 23 States have passed more stringent laws for some specific and sometimes sensitive health data (e.g., mental health or HIV data). Because this data type is generally not the focus of HIEs, we focus only on laws restricting the exchange of general health information. Overview of HIE-Specific Legislation
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Incentives and PrivNoConsent
Incentives only passed HIE-specific legislation into one of three main categories:
24
• Incentives and PrivConsent: states with laws intended to encourage the pursuit of HIEs and that have requirements for patient consent (eight states).
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• Incentives and PrivNoConsent: states with laws intended to encourage the pursuit of HIEs and that make some mention of privacy protections but do not include requirements for consent (i.e., they rely on the status quo of no consent requirements for the exchange of health information between healthcare entities) (11 states).
• Incentives: states with laws intended to encourage the pursuit of HIEs but that make no mention of privacy protections; these states also did not have any preexisting general health privacy laws that would require consent in the context of exchange (three states and the District of Columbia). Figure 2 identifies the states that have enacted HIEspecific legislation. In addition, we identified three states that passed or amended health privacy laws that instituted privacy requirements for HIEs without accompanying incentives. During the time period of our analysis, Nevada and New Mexico passed health privacy legislation that explicitly mentioned exchange but did not institute consent requirements for the exchange of health information between healthcare entities for treatment purposes (similar to general health disclosure laws discussed previously). Conversely, Maine amended existing privacy legislation to 24 See EC.1 in the electronic companion (available as supplemental material at http://dx.doi.org/10.1287/mnsc.2015.2194) for additional example statutes and text. 25 Specifically, under this category, we consider any law that mandates that patients are provided with notice before the exchange of their personal health information in an HIE and, at a minimum, that patients are also provided with the choice to exclude their information from such an exchange as having consent requirements.
require patient consent prior to the exchange of patient health information. This leaves 25 states that did not pass HIE-specific legislation during our time period.
Methods
Our empirical approach leverages time-series regression using longitudinal data on planning and operational HIEs across HRRs, as well ascross-sectional analysis using survey data on individual HIEs.
Model 1: Fixed Effects Model
The first model we estimate is a panel linear probability model that includes HRR and time fixed effects with reported standard errors clustered at the state level. This model evaluates the impact of HIEspecific legislation on HIE creation (PlanningHIE jst ) and reaching operational status (OperationalHIE jst ) in healthcare market j, in state s, at time t.
26 This model identifies the baseline effects on these variables of 26 In our context, nonlinear models with fixed effects (e.g., logit) are not desirable because they leverage only variation across time. In our analysis, this precludes a significant portion of our data and would result in a specification with estimations using HRR fixed effects failing to converge. The central limitation to the linear probability model is that the predicted probabilities are not constrained between 0 and 1, thus requiring some caution when interpreting coefficient estimates. However, prior work has shown little qualitative difference between the logit and linear probability specification (Angrist and Pischke 2008) , and prior empirical work in this field has leveraged identical approaches Tucker 2009, Goldfarb and Tucker 2011) . In addition to the practical limitations associated with nonlinear fixed effects models, scholars (e.g., Neyman and Scott 1948) have demonstrated that estimates from nonlinear fixed effects models are inconsistent because the asymptotic variance of the main parameters is a function of a small and assumed fixed group size; this is also known as the incidental parameter problem. Greene (2002) finds this problem to be of significant practical consequence with slope estimates from nonlinear fixed effects models uniformly biased away from zero compounded by estimates of the standard errors biased toward zero. Here, PrivConsent st is a dummy variable indicating whether a state s at time t had a privacy law that also required patient consent in the context of exchange, and PrivNoConsent st is a dummy variable indicating whether a state had a privacy law in place but did not require patient consent in the context of exchange. In this model, PrivConsent st and PrivNoConsent st capture the impact of privacy regulation that was passed without accompanying incentives. Moreover, Incentives st is a dummy variable indicating whether a state s had legislation providing HIE incentives at time t (where t represents semiannual intervals). We also include the interactions PrivConsent st × Incentives st and PrivNoConsent st × Incentives st to identify any differential impact of incentives when varying degrees of privacy protections are present. These interactions take into account other potentially relevant privacy legislation. For example, if a state had passed legislation with HIE incentives during our time period of analysis without privacy provisions but either during or prior to our period of analysis also passed privacy requirements relevant to exchange in separate legislation, this interaction would be positive.
We also created variables to differentiate between the most common provisions in state laws incentivizing HIE efforts. We found that states differed in terms of whether they provided explicit funding in legislation incentivizing HIEs; some states provided funds explicitly authorized for use in support of HIE efforts, whereas other states directed responsible entities to identify sources of financial support for exchange efforts or were ambiguous regarding financial support from the state. Thus, our first variable captures HIE incentives with explicit funding opportunities (Funding st . In addition, we captured differences in states' propensity to focus HIE incentives on creating or designating a statewide exchange versus focusing HIE incentives on HIE efforts in disparate healthcare markets. Thus, our second variable captures states with laws that designate or create a state-sponsored HIE (StateDesignated st . We include these variables in our model to address the concern that the variation in state strategies toward HIE incentives may correlate with a particular legislative approach. If this were the case, the effect of a given legislative approach could be driven by the intensity or nature of HIE incentives.
Finally, we include a vector of control variables, X jst , which accounts for other factors relevant to the emergence of planning and operational HIEs. For example, HIE efforts may require that regional healthcare entities have some minimum level of patient record digitization and health IT infrastructure in order to engage in electronic exchange, which could be correlated with privacy regulation. As a result, we control for healthcare IT adoption in the HRR by including CPOEAdoption jst to capture hospital adoption of computerized provider order entry (CPOE).
27 CPOE is often a proxy for advanced adoption of healthcare IT and is highly correlated with the adoption of other healthcare IT (e.g., electronic medical records). It is also a core component of the federal definition of "meaningful use" of electronic health records (Blumenthal and Tavenner 2010) . Other HRR-level controls include those capturing population, median income, and unemployment rates. HRR and time fixed effects are represented by js and t , respectively; jst is the error term. We evaluate whether multicollinearity is a concern in the estimation of this model by calculating correlation tables and the variance inflation factor (VIF) for each independent variable in the model. We find that all variables have a VIF well below the recommended maximum of 10 (Kennedy 1992), with a mean VIF of 1.9 for the variables in our panel estimation (see EC.2 in the electronic companion). Similar fixed effects models have been used in the literature to examine the effect of a policy intervention (Bertrand et al. 2004) . HRR fixed effects allow us to control for time-invariant unobserved factors and time dummies allow us to control for time trends. Thus, the unbiased effect of varied regulatory approaches can be identified from variation across HRRs and time. In an extended specification, we include one-year lagged variables to allow for a delayed effect on HIE outcomes of legislation aimed at incentivizing HIE efforts with and without privacy regulation. This accounts for the potential for resources provided by these laws to take time to reach entities interested in pursuing HIE. 
Model 2: Cross-Sectional Model
The second model we estimate also uses a linear probability model and standard errors clustered at 27 Based on data obtained from HADB. 28 For clarity of exposition, we exclude the lagged terms for the binary indicators of states having privacy regulation alone (PrivConsent and PrivNoConsent) since the lagged effect of this legislative approach is not of central interest and was rare in our data set. the state level but uses cross-sectional survey data. Our survey data captured a detailed snapshot of HIEs' status and activities as of the end of 2009. This model evaluates the association between relevant HIE characteristics (described below) and the varying approaches toward incentivizing HIE efforts (i.e., those with and without consent-based regulation):
Here, Incentives s is a binary indicator of whether an HIE is operating in a state s with HIE incentives. The interaction between Incentives s * PrivConsent s captures any differential impact of having consent requirements alongside HIE incentives. Because states with privacy regulation without incentives had only two operational and three planning exchanges, we do not attempt to estimate effects for these legislative approaches. However, to avoid biased interpretation of our estimates, we exclude these HIEs from our estimation for model 2. This model does include a vector of state-level controls, X s , which accounts for state political leaning, wealth, population, age structure, and education levels, as well as a vector, Z is , of HIE-level controls including measures of the length of time an HIE has been pursuing exchange and whether they have a formal governance structure. Although we do include a number of state-and HIE-level controls, we cannot include HIE or regional fixed effects. As a result, the estimates from model 2 should be interpreted with some caution. However, we argue that the most problematic endogeneity concerns are unlikely in the context of our analysis.
For instance, we use this model primarily to evaluate the association among HIE incentives, consent requirements, and HIE privacy challenges. Specifically, we use a binary measure of whether an HIE i in state s reported that privacy concerns were a major challenge or impediment to their development (PrivChallenge is to evaluate our previous conjecture that incentives for HIEs may be associated with an increased attention to and salience of privacy concerns, which could materialize as barriers to the emergence of HIEs. In the context of this analysis, one concern may be that heterogeneity in states' tastes for privacy would both impact their propensity to have consent requirements, as well as the pushback HIEs face from privacy concerns. However, our predictions would actually be made less likely by this effect, since we conjecture that HIEs in states with consent requirements will, in fact, report less pushback as a result of patient privacy concerns. For a similar reason, we consider reverse causality in which low initial privacy concerns resulted in states being more likely to pass consent requirements as also being unlikely.
Additionally, we use this model to evaluate whether relevant heterogeneity exists in key individual characteristics of HIEs across states with and without consent requirements. For example, because availability of funding (beyond that from the government) has been shown to significantly affect the choice to pursue exchange (Adler-Milstein et al. 2009 ), we evaluate the correlation between consent requirements and the availability of funding to HIEs. Although our panel estimation controls for legislation with explicit funding opportunities as part of their HIE incentives, this may not suffice, because HIEs may leverage a range of funding sources including those provided by the federal government and other private sources (e.g., large health systems or physician groups). As a result, we include the variable FundChallenge is as a binary measure indicating whether HIE i in state s reported that the lack of funding was a major challenge to their development. Finally, we evaluate whether HIEs in states with consent requirements varied with respect to other characteristics that are also indicative of HIE progress and their ability to achieve desired goals. Specifically, we evaluate differences in the number of patients covered by an exchange (HighPatientHIE is across states with and without consent requirements.
Results
The results for the fixed effects model (model 1) are presented in Table 2 . We find that privacy regulation without incentives had a negative effect on the pursuit of HIE. However, this effect varied depending on the stage of HIE development. For privacy regulation with consent requirements (PrivConsent), we find a large negative and significant coefficient for PlanningHIE (column (A)). However, a similarly negative coefficient for OperationalHIE is not significant (p = 0 171, column (B)). For privacy regulation without consent requirements (PrivNoConsent), we find a significant negative coefficient for OperationalHIE but a near-zero and insignificant estimate for PlanningHIE. This suggests that, although privacy regulation without consent had a significant effect on HIEs reaching operational status, it does not seem to dissuade entities from initially pursuing HIE.
We find small and generally insignificant estimates on Incentives, suggesting that HRRs in states that provided HIE incentives without accompanying privacy provisions did not see increases in HIEs. However, we do find a significant and positive coefficient on the interaction of PrivNoConsent and Incentives, but only for OperationalHIE. This suggests that incentives passed alongside regulation without consent requirements resulted in a 9% increase in the probability Downloaded from informs.org by [128.237.116 .93] on 16 March 2018, at 08:44 . For personal use only, all rights reserved. Note. Robust standard errors are shown in parentheses. + p < 0 1; * p < 0 05; * * p < 0 01.
of an HRR having an operational exchange but no measurable effect on the propensity of initiating an exchange. Finally, we find consistent and significant gains from HIE incentives when they were coupled with privacy regulation providing patient consent requirements. Specifically, we find a large and significant coefficient on the interaction of PrivConsent and Incentives for both PlanningHIE (p < 0 01) and OperationalHIE (p < 0 01), suggesting that incentives passed alongside privacy regulation with consent requirements resulted in a 47% increase in the probability of HRRs having a planning exchange and a 23% increase in the probability of HRRs having an operational exchange. Moreover, the difference in the effectiveness of incentives coupled with consent requirements was statistically significant when compared with the incentives alone (Incentives) or incentives with regulation without consent (Incentives × PrivNoConsent) for both PlanningHIE (p < 0 01) and OperationalHIE (p < 0 05). Given that we find evidence of negative baseline effects of privacy regulation, we also consider the net effect for states with legislative approaches that combined incentives and privacy regulation. For instance, although HIE incentives coupled with privacy regulation without consent requirements resulted in a 9% increase in the probability of HRRs having an operational exchange, this effect was offset by the negative (10%) baseline effect of the privacy regulation, resulting in a zero net effect on the propensity of HRRs in these states to have operational HIEs. By contrast, we find evidence of a net gain in operational HIEs for HRRs in states with both HIE incentives and privacy regulation with consent requirements. Specifically, we identify an 11% (p < 0 05) net increase for Operational-HIE and also a 10% net increase (although insignificant, p = 0 22) for PlanningHIE. Within our data set, HIE incentives coupled with consent requirements was the only legislative approach with evidence of a net gain in OperationalHIE.
Estimates of our main model with lagged variables are presented in Table 2 , columns (C) and (D). We find that estimates on our baseline interaction of Incentives and PrivConsent for PlanningHIE are of similar magnitude to our primary estimation and are significant Downloaded from informs.org by [128.237.116 .93] on 16 March 2018, at 08:44 . For personal use only, all rights reserved.
(p < 0 05), whereas our lagged term has a small and insignificant coefficient. This suggests that new HIEs were planned within a short period of the passage of these laws and may reflect the relatively low costs of initiating an exchange and that parties interested in pursuing HIE closely tracked the progression of these laws. However, we may reasonably expect that the effect of legislation on the propensity of an exchange actually becoming operational may be less immediate, because the resources afforded by these laws may be critical in exchanges advancing their capabilities. We find some support for this notion, with the coefficient on our baseline interaction of Incentives and PrivConsent for OperationalHIE roughly half the magnitude of our primary estimation (13.5% versus 23.0%). Our lagged term, however, is larger (11.7%) but less precisely estimated (p = 0 24), suggesting some variability in the lagged effect of relevant legislation. We should note that we are not able to observe lagged effects for states that passed laws within the last year of our panel (Oregon and Alaska), which may also be contributing to higher standard errors for estimation of our lagged term.
The results from our cross-sectional model (see Table 3 ) offer some explanation for the differential HIE gains from incentives coupled with consent requirements and also address alternative interpretations of our results. First, we evaluate the validity of our earlier conjecture that the effectiveness of incentives with consent requirements is driven by the propensity of consent requirements to address elevated consumer privacy concerns associated with HIE incentives. We find evidence in support of this conjecture with HIE incentives not coupled with consent requirements positively associated with increased scrutiny and privacy concerns. Specifically, we find that HIEs in states with HIE incentives but without consent requirements were 30% more likely to report that privacy was a major challenge compared with HIEs in states with incentives and consent requirements (p < 0 01) and 14% more likely to report that privacy was a major challenge in their development compared with states without any legislation (p < 0 05). HIEs in states with incentives and consent requirements were least likely to report major privacy challenges compared with all other legislative approaches (p < 0 01).
Results from our cross-sectional model also help to rule out what we considered the most prominent confounding factors to the interpretations of our results. First, we consider whether our results merely reflect heterogeneity in the propensity of incentives coupled with consent requirements to provide funding opportunities for HIE efforts (the lack of sufficient financial support has been a prominent barrier to HIE development). Although we account Notes. Robust standard errors are shown in parentheses. The number of observations varies because of some nonresponses in the survey; column (C) only uses responses from operational exchanges. + p < 0 1; * p < 0 05; * * p < 0 01.
for this in our panel estimation by controlling for HIE incentives with funding opportunities (Funding), we address this concern further by evaluating any association between HIE self-reported funding challenges and incentives that included consent requirements. We do not find support for the notion that HIEs in states with consent requirements significantly differed with respect to their access to sources of funding: column (B) in Table 3 shows that, although HIEs in states with HIE incentives were 24% less likely to report that funding was a major challenge (p < 0 05), there is no significant correlation between consent requirements and funding being a major challenge for HIEs with an insignificant estimate on Incentives s × PrivConsent s . In addition, we evaluate whether legislative approaches coupling incentives with consent requirements actually resulted in a positive effect on exchange capabilities in a healthcare market. Specifically, it may be the case that, although legislative approaches coupling incentives with consent result in a higher likelihood of an exchange being operational, these exchanges may have less extensive or comprehensive exchange capabilities. We do not find evidence of this, however, with an insignificant estimate on Incentives s × PrivConsent s for HighPatientHIE Downloaded from informs.org by [128.237.116 .93] on 16 March 2018, at 08:44 . For personal use only, all rights reserved.
(column (C)). In fact, the positive estimate on this coefficient suggests that HIEs in states with both incentives and consent requirements trended toward covering more patients, not fewer.
Robustness
We evaluated the robustness of our primary results (model 1) by examining concerns regarding (1) the endogenous passing of legislation providing incentives and consent, (2) our assumption that HRRs are subject to only one legislative approach, and (3) incentive heterogeneity and high-impact states.
Endogeneity of Incentives and Consent
The results presented in §6 highlighted the unique role of consent requirements combined with HIE incentives in spurring the emergence of planning and operational HIEs. The model we estimate was identified using HRR and time fixed effects to isolate within-HRR variation over time and controls that could be correlated with the legislative initiatives of interest and the pursuit of HIE. However, a state's choice of a particular legislative approach is certainly not random, exposing our estimates to potential bias if there exists time-varying heterogeneity between states with certain legislative approaches that also contributes to the success of HIEs. Although the direction of this bias is ambiguous (i.e., it is possible that the potential bias in our results makes our results more conservative), we focus on the potential bias, which could result in the overestimation of our central result.
First, rather than HIE laws driving HIE activity, these laws could instead be passed as a result of increased HIE activity. To assess this possibility, we plotted the total number of attempted HIEs (planning plus operational) for the main HIE legislative approaches we identified. Figure 3 reveals that states that ultimately passed consent requirements did not have elevated levels of HIE activity before the passage of the law. In fact, they had the lowest level of HIE activity when compared with other legislative approaches. More generally, before the period in which most HIE laws were passed (pre-2007) , there were minor differences in the number of attempted HIEs. However, as we move into 2007, states with no legislation or incentives without consent maintain a roughly constant rate of growth, whereas states that coupled incentives with consent requirements see a significant increase in attempted HIEs. We further evaluate possible reverse causality by estimating our main model with one-time-period lead variables for the legal requirements (see columns (A) and (B) in Table 4 ). This allows us to evaluate whether the trends of increased planning and operational HIEs were, in fact, in existence prior to the enactment of relevant 
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No HIE law HIE laws. We find that our initial result is robust to the inclusion of lead variables and that the estimates on our lead variables, including the interaction of incentives and consent requirements, are insignificant. In addition, our main estimation evaluates the impact on HIE efforts of legislation with HIE incentives compared with states without any such legislation. However, HIE incentives may be correlated with time-varying state unobservables that also impact HIE outcomes. For example, HIE incentives may be correlated with changes in political attitudes or public opinion toward the importance of health IT, which is likely to also have an impact on the emergence of HIE efforts. As a result, we evaluate whether our results are being driven by differences between states with and without HIE incentives. Specifically, we estimate our model using only the subset of states that have legislation with HIE incentives (columns (C) and (D) in Table 4 ). The results are consistent with those in our original estimation with a sizable and significant (p < 0 05) impact of Incentives × PrivConsent on both PlanningHIE and OperationalHIE. In addition, we argue that the heterogeneous effects on HIE efforts of incentives (e.g., incentives without consent had a marginal or no effect on HIE efforts) make it less likely that unobserved factors, correlated over time with HIE incentives, are systematically driving HIE efforts.
With respect to the endogeneity of privacy regulation, prior work (e.g., Miller and Tucker 2011) has used privacy regulation limiting the disclosure of health information as an instrumental variable in the estimation of the effect of EMR adoption on healthcare outcomes, arguing and presenting evidence that such regulations are likely exogenous to shifts in states' focus on healthcare issues and political motivations. Similar to such analysis, we find that states with consent requirements varied considerably in terms of geographic location, size, and state political affiliation. Moreover, we propose, similar to the case against the Downloaded from informs.org by [128.237.116 endogeneity of HIE incentives, that our results partially shield us from these concerns. If unobserved factors are powerfully driving HIE efforts and these factors are correlated, over time, with privacy regulation, the divergent effects of privacy regulation (e.g., privacy regulation without incentives actually inhibited HIE efforts) would be considerably more difficult to identify. Since we focus on the interaction of privacy regulation with incentives, we are still concerned that specific legislative approaches, particularly legislative approaches that couple incentives with consent requirements, could be differentially correlated with other unobserved factors over time that could also drive the emergence of planning and operational HIEs. For instance, it is possible that legislative approaches coupling consent requirements with incentives are also associated with changes in attitudes toward health IT and the value of technology in healthcare settings. However, we consider this unlikely, because HIEs have expressed significant concerns over consent-based regulation. For instance, in a recent report (National eHealth Collaborative 2011), HIE administrators suggested that requiring patients to opt in to an HIE was a barrier to achieving the critical mass of patient records needed to generate theorized benefits. As a result, we suggest that it is more likely that states that adopt consent requirements signal a shift toward a more tempered attitude toward the trade-offs associated with health IT relative to states with HIE incentives alongside less stringent regulation, likely making our results more conservative. Finally, the combination of incentives and consent requirements could reflect the sophistication of state legislative bodies in anticipating and proactively addressing the central concerns associated with increased HIE activity in the state. This sophistication could also be correlated with better administered, managed, and otherwise executed incentive programs that yield improved HIE outcomes. To evaluate this concern, we leverage work by Squire (2007) Although we take a number of steps to consider and evaluate potential endogeneity of legislative efforts, we acknowledge that these concerns may persist to some degree, as they often do with empirical work of this nature.
HRR Boundaries
Measuring HIE activity at the level of an HRR allows us to identify the impact of legislation on the propensity of an HIE to be operational or in the planning stage within relatively self-contained healthcare markets; it also allows for meaningful comparison across states with regions subject to varying legislative approaches. This approach requires us to assume that each HRR is contained within a single state and thus a single legislative approach. However, HRR boundaries can sometimes span multiple states that may have different legislative approaches. We find that this is fairly uncommon, with 80% of HRRs either being fully contained in a single state or overlapping with states that had the same legislative approach. An additional 11% of HRRs had minor overlap (less than 25% of their population) in states with different legislative approaches. When we exclude the remaining 9% of HRRs, which had significant overlap in states with different legislation approaches, and estimate our main model (see Table 4 , columns (E) and (F)), we find consistent results with our original estimation. 
Incentive Heterogeneity and
High-Impact States Although we control for the most prominent variation in the strategies that states take toward HIE incentives, there may also be other HIE incentives that are less common in our analysis but may still have an impact on the nature of HIE incentives and also on HIE outcomes. Specifically, we identified four other features of HIE incentives that were less frequent but still of potential interest: whether HIE incentives were directed to an existing private organization as opposed to a government entity, whether HIE incentives instituted a pilot program, whether incentives addressed existing regulation viewed as an impediment to HIE progress, and whether incentives had an interstate dimension. To evaluate whether these less common features of HIE incentives impact our estimation, we estimate our main model with additional controls capturing these less frequent features of HIE incentives and find consistent results with our main estimation (see EC.3 in the electronic companion). Because our analysis relies on a limited number of states, it is also possible that our results are not due to a correlation between consent requirements and incentives but by a single state with unique HIE incentives or with disproportionate HIE success as a result of factors not captured in our model. To address this concern, we limit our analysis to states with HIE incentives and sequentially exclude all regions in a given state that coupled incentives with consent requirements from our estimation for PlanningHIE and OperationalHIE (see EC.3 in the electronic companion). We find that our results for PlanningHIE and OperationalHIE are robust to sequential exclusion of states with incentives and consent requirements. Excluding New York seems to have the largest impact on estimates of the effect of incentives coupled with consent requirements, but these estimates are still significant for OperationalHIE and marginally significant for PlanningHIE.
Discussion and Conclusions
We evaluated the impact of legislation that varied in whether it included requirements for patient consent and provided HIE incentives over a span of six years. We document a surprising interplay between state attempts to incentivize HIE efforts and privacy regulation. Specifically, although privacy regulation alone-and, in particular, regulation with consent requirements-resulted in a negative effect on HIE efforts, coupling HIE incentives with consent requirements was the only legislative approach intended to encourage HIE efforts that actually resulted in an increase in operational HIEs. We find that this result is robust to considerations of reverse causality, endogeneity of HIE incentives and consent requirements, considerations of HRR legislative boundaries, incentive heterogeneity, and a single state driving the effect. We also find that HIEs in states with both incentives and consent requirements reported lower levels of concern about patient privacy issues, whereas exchanges in states with HIE incentives but without consent requirements reported higher levels of patient privacy concerns. We propose that this elevated concern may be due to an association between HIE incentives and privacy concerns that inhibit the effectiveness of such incentives when consent requirements are not in place.
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the full breadth of potential measures of success for HIEs. For instance, prior research on HIEs has noted that sharing by HIEs has been limited in breadth and scope (Adler-Milstein et al. 2009 ). We evaluate these measures using cross-sectional data, but future work may evaluate the impact of various legislative approaches on these measures in more substantive terms. Moreover, an increase in regional HIE efforts may not necessarily be a positive outcome. For example, a better outcome might be to have only one exchange that facilitates exchange for all providers in the state. However, the current national strategy for the exchange of health information involves spurring small regional efforts and then linking them as building blocks of state and national exchange (Vest and Gamm 2010) . As is true in prior work, we can thus view a higher probability of HIEs in planning and operational stages in HRRs as a positive indicator of HIE progress. Moreover, our work focuses specifically on the role of providing patients with the choice to consent in the context of HIEs, but other key concerns with HIEs may also be relevant. For example, it may be prudent in future work to evaluate the role of information security requirements on the development and progress of HIEs. Finally, this paper focuses on regional models of HIE and, although alternative approaches to HIE exist (e.g., national EMR vendor HIE networks), we use an inclusive and widely held definition of clinical data exchange between unaffiliated entities (i.e., those with no shared ownership or governance). Moreover, regional efforts are more likely to capture the full benefits of HIE because the other approaches (e.g., vendor driven) restrict data exchange in some way. It is therefore critical to understand the conditions under which the HIE efforts included in our study can succeed and, in particular, the policy conditions that foster their success.
Our results help to inform the large national effort underway to achieve the broad-based exchange of health information. Given that HIEs offer innovative healthcare technology solutions with the potential to alleviate two of the most pressing concerns of the current healthcare system-rising costs and inconsistent quality-this study proposes a complementarity of technology incentives and substantive consumer privacy protections, highlighting the potential for future efforts to incentivize HIE growth while balancing patient privacy concerns. Such results may help to inform the broader debate on the role of privacy regulation in information technology efforts. First, the findings highlight the potential for the negative effects of privacy regulation on information technology efforts to be counteracted by technology incentives. Additionally, the focus on both the impact of technology incentives and privacy requirements extends the growing body of empirical work in this space and bolsters the notion that privacy regulation can have heterogeneous and complex effects on information technology efforts. Specifically, we suggest that a symbiotic relationship may exist between technology incentives and substantive privacy regulation with simultaneous benefit to both consumers and proponents of information technology efforts. This yields a possible lesson for regulators and policy makers: legislative approaches that both incentivize technology efforts and provide consumer privacy protections may be one approach for enabling the growth of valuable information technology efforts while addressing consumer privacy concerns.
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